Want to join the conversation?
Diversified healthcare company $JNJ reported a 11.5% drop in 2Q16 earnings due to higher research and development expense as well as intangible amortization expense and special items charge. Net income fell to $4Bil or $1.43 per share from $4.52Bil or $1.61 per share last year. Adjusted EPS increased to $1.74 from $1.71.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?